Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03303391 · ClinicalTrials.gov registry record · NA
Using Intradialytic Blood Pressure Slopes to Guide Ultrafiltration
A NA study, sponsored by University of Texas Southwestern Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT03303391 is a NA study that was terminated before completion, run by University of Texas Southwestern Medical Center. The registered enrollment target is 14 participants.
The verdict
NCT03303391, a NA study, was terminated before completion, sponsored by University of Texas Southwestern Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
This study is an open label randomized clinical trial that comparing intradialytic blood pressure slope-based ultrafiltration prescriptions to standard care in the chronic fluid management of maintenance hemodialysis patients. It also includes a cross sectional component evaluating the associations between intradialytic blood pressure slopes ascertained over 2 week periods with measurements of extracellular water/body weight obtained with multifrequency bioimpedance spectroscopy.
Interventions
- OTHER Intradialytic Blood Pressure Slope Based Ultrafiltration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2017-11-01 |
| Est. Completion | 2020-01-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03303391
The ClinicalTrials.gov registry entry for NCT03303391 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Intradialytic Blood Pressure Slope Based Ultrafiltration is the first listed.
NCT03303391 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03303391 about?
NCT03303391 is a clinical study titled "Using Intradialytic Blood Pressure Slopes to Guide Ultrafiltration". This study is an open label randomized clinical trial that comparing intradialytic blood pressure slope-based ultrafiltration prescriptions to standard care in the chronic fluid management of maintenance hemodialysis patients. It also includes a cross sectional component evaluating the associations ...
What is the current status of trial NCT03303391?
This trial is currently terminated. It is a NA study. The enrollment target is 14 participants. The study started on 2017-11-01. Estimated completion is 2020-01-01.
What interventions are being tested in trial NCT03303391?
The interventions under investigation include: Intradialytic Blood Pressure Slope Based Ultrafiltration (OTHER).
Who is sponsoring clinical trial NCT03303391?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.